SURPASS Webinar and Proposers' Day Information

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)

Contract Value

Not provided

Codes & Classification
Solicitation Number

ARPA-H-SN-26-164

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Classification Code

AN13

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Advanced Research Projects Agency for Health (ARPA-H), operating under the Department of Health and Human Services and the National Institutes of Health, has issued a Special Notice (ARPA-H-SN-26-164) to inform interested parties about upcoming informational events related to its Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) Program. This notice serves as an invitation to review details regarding a webinar scheduled for October 15, 2026, and a two-day Proposers’ Day event on November 6 and 9, 2026. These events are designed to provide prospective contractors and collaborators with critical information about the SURPASS initiative, its objectives, and the solicitation process. The SURPASS Program aims to advance research and development in biotechnology, specifically excluding nanobiotechnology, as classified under NAICS Code 541714. The program is expected to leverage simulation-augmented and real-time adaptive trial platforms to enhance the efficiency and effectiveness of clinical research. The intended outcomes include fostering innovative approaches to seamless trial design, improving adaptability, and accelerating the translation of biomedical discoveries into health solutions. Key requirements and objectives for this procurement will be further detailed in the associated solicitation (ARPA-H-SOL-26-164), which interested parties are encouraged to review for comprehensive guidance. The expected deliverables will likely focus on the development and implementation of advanced trial platforms, integration of real-time data, and demonstration of adaptive methodologies that support the SURPASS mission. The contracting entity for this opportunity is ARPA-H, a federal office within the NIH, with organizational key 500183629. The primary point of contact for all inquiries is the SURPASS Team, reachable at [email protected]. The notice remains active, with a response deadline set for October 13, 2026, at 03:10. Additional information, including attachments, can be accessed via the official SAM.gov opportunity page at https://sam.gov/opp/5cfa2b9ca4db47179027a786cbaba33a/view. This procurement is classified under Product Service Code AN13, which pertains to research and development activities. While the notice does not specify set-aside requirements or special considerations, contractors specializing in biotechnology research and adaptive clinical trial methodologies are encouraged to evaluate their alignment with the SURPASS program’s scope and objectives. Overall, this Special Notice provides a valuable opportunity for organizations with expertise in biotechnology R&D to engage with ARPA-H, gain insight into the SURPASS program, and prepare for participation in the solicitation process. The informational events are intended to clarify program requirements, foster collaboration, and ensure that potential proposers are well-equipped to contribute to the advancement of adaptive clinical trial platforms.